Delfina Care
Integrated pregnancy platform delivering personalized care based on deep insights into each member's needs
Company profile
Company profile
Delfina is a maternal health technology company addressing the maternal health crisis in the United States through its integrated pregnancy data platform, Delfina Care. The company delivers personalized pregnancy care based on deep insights into each member's needs, combining AI-driven risk identification with high-touch, culturally competent support. Delfina's platform enables care teams to automate routine tasks and activate proactive care pathways to prevent complications, while pregnant members receive access to education, continuous doula support, telehealth services, and at-home monitoring through an engaging mobile app. The company serves healthcare providers, health plans, and employers nationwide, offering equitable access to pregnancy care across diverse populations. Delfina's high-risk care pathways are designed to reduce complications in pregnancy and birth, with the company guaranteeing same-year minimum ROI for health plan partners. The platform provides data for quality improvement reporting including HEDIS, NCQA, and CMS measures, and has achieved an 83.3 NPS score with a 5-star app store rating. Founded by doctors for doctors, Delfina partners with organizations including the National Association of Community Health Centers (NACHC) and Mayo Clinic to expand access to proactive maternal health support, particularly for communities facing the greatest barriers to healthcare access.
Company description Delfina official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Selected for inaugural NACHC Accelerator 2026 cohort (March 2026). Partnership with Mayo Clinic announced for personalized metabolic health program. Transforming pregnancy care in California initiative. Partnership with NACHC to support community clinics across the country.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Integrated pregnancy platform delivering personalized care based on deep insights into each member's needs
Mobile app providing pregnant members with education, doula support, telehealth, and at-home monitoring
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Science & justice : journal of the Forensic Science Society · Sep 1, 2026
Convergence and divergence of mental health symptoms among adolescents and their friends.European child & adolescent psychiatry · Aug 24, 2026
Self-medication with herbal remedies and pharmaceuticals for COVID-19 among healthcare students in Maputo.Scientific reports · Jun 16, 2026
Childhood trauma assessed using the childhood trauma questionnaire and its influence on pediatric mood disorders and self-harm: a systematic review and meta-analysis.Child abuse & neglect · May 1, 2026
Uncovering the diversity of microalgal harmful species in Chile through multidisciplinary characterization.Marine pollution bulletin · Apr 1, 2026
Science diplomacy, research and global health.Nature microbiology · Apr 1, 2026
Clinical validation
NCT07188506 · Mentioned · RECRUITING
Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration TargetsNCT07681544 · Mentioned · COMPLETED
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesNCT06671483 · Mentioned · RECRUITING
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque PsoriasisNCT04772079 · Mentioned · RECRUITING
Effect of Spinae Erector Block (ESP) and Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion PatientsNCT06096480 · Mentioned · UNKNOWN
Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver DiseaseNCT05913986 · Mentioned · UNKNOWN
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Member satisfaction as of 6/30/24
Mobile app user satisfaction
Maternal health complications and interventions
Guaranteed for health plan partners
Transforming pregnancy care in California with partnership involving California Surgeon General Dr. Diana Ramos
Transforming pregnancy care delivery across California
Supporting community health centers across the country to improve maternal health outcomes for underserved populations
Selected for inaugural NACHC Accelerator 2026 cohort to expand proactive maternal health innovation to more communities nationwide
Closing the loop with providers between appointments and helping members know when to seek extra support
Members now have a way to communicate with providers between appointments
Creating personalized metabolic health program for expecting mothers
Partnership to develop personalized metabolic health program
Managing preeclampsia case by enabling patient to share symptoms and blood pressure values
Delfina was instrumental in managing the preeclampsia case appropriately
05 · Leadership
Leadership profiles and professional links from the current Company record.
Senan Ebrahim
Chief Executive Officer
Isabel Fulcher
Chief Scientific Officer
Bonnie Zell
Chief Medical Officer
Ali Ebrahim
Chief Technology Officer
Regan Theiler
Associate Chief Medical Officer
Mary Parman
President, Delfina Medical Group
Andy Hobbs
VP of Provider Partnerships
Jessica Barra
VP of Clinical Innovation
06 · Company updates
Recent articles published on Delfina's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.